Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.
Vrede SW, Van Weelden WJ, Bulten J, Gilks CB, Teerenstra S, Huvila J, Matias-Guiu X, Gil-Moreno A, Asberger J, Sweegers S, van der Putten LJM, Küsters-Vandevelde HVN, Reijnen C, Colas E, Hausnerová J, Weinberger V, Snijders MPLM, Vinklerova P, Ravaggi A, Odicino F, Bignotti E, McAlpine JN, Kruitwagen R, Pijnenborg JMA.
Vrede SW, et al. Among authors: matias guiu x.
Gynecol Oncol. 2024 Nov 7;192:15-23. doi: 10.1016/j.ygyno.2024.10.028. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 39515079
Free article.